title: Benzo[a]pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone.
abstract: Wild-type MCF-7 human breast cancer cells were cultured for 3 months in 1 microM benzo[a]pyrene (BaP), and resistant clones were screened for inducibility of CYP1A1 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). One of the BaP-resistant (BaPR) clones exhibited unique genotypic expression which distinguished it from both wild-type and drug-resistant (AdrR) variant MCF-7 cells. Glutathione levels, glutathione S-transferase activities, estrogen receptor levels, estrogen responsiveness, and expression of the multidrug-resistant MDR1 and MRP mRNA levels were similar in the wild-type and BaPR cells, whereas these parameters were reported to be altered in AdrR cells. In contrast, TCDD induced CYP1A1 gene expression and inhibited selected estrogen-induced responses in wild-type but not BaPR MCF-7 cells. Treatment of wild-type and BaPR cells with [3H]TCDD resulted in formation of the radiolabeled aryl hydrocarbon (Ah) 6 S nuclear receptor complex in both cell lines. The loss of Ah responsiveness in the BaPR variant cells correlated with the failure of the nuclear or transformed cytosolic Ah receptor complex to bind genomic dioxin-responsive elements as determined in gel retardation assays.
authors.affiliation: Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station 77843-4466.
authors.forename: M
authors.initials: M
authors.lastname: Moore
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: Y F
authors.initials: YF
authors.lastname: Lu
authors.forename: M
authors.initials: M
authors.lastname: Wormke
authors.forename: A
authors.initials: A
authors.lastname: Craig
authors.forename: J H
authors.initials: JH
authors.lastname: Gerlach
authors.forename: R
authors.initials: R
authors.lastname: Burghardt
authors.forename: R
authors.initials: R
authors.lastname: Barhoumi
authors.forename: S
authors.initials: S
authors.lastname: Safe
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D001483:Base Sequence; D001564:Benzo(a)pyrene / Q000378:metabolism / Q000633:toxicity*; D001943:Breast Neoplasms; D002352:Carrier Proteins / Q000096:biosynthesis; D002467:Cell Nucleus / Q000378:metabolism; D002999:Clone Cells; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis*; D004351:Drug Resistance / Q000235:genetics; D004790:Enzyme Induction; D004958:Estradiol / Q000378:metabolism; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D008562:Membrane Glycoproteins / Q000096:biosynthesis; D008969:Molecular Sequence Data; D016296:Mutagenesis; D000072317:Polychlorinated Dibenzodioxins / Q000378:metabolism / Q000494:pharmacology*; D012333:RNA, Messenger / Q000096:biosynthesis; D018336:Receptors, Aryl Hydrocarbon / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D014407:Tumor Cells, Cultured
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D000072317:Polychlorinated Dibenzodioxins; D012333:RNA, Messenger; D018336:Receptors, Aryl Hydrocarbon; D011960:Receptors, Estrogen; D001564:Benzo(a)pyrene; D004958:Estradiol; D003577:Cytochrome P-450 Enzyme System